{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:32:18Z","timestamp":1775817138181,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1002\/jps.21711","type":"journal-article","created":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T20:12:01Z","timestamp":1238616721000},"page":"4130-4140","source":"Crossref","is-referenced-by-count":63,"title":["Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis"],"prefix":"10.1016","volume":"98","author":[{"given":"Anroop B.","family":"Nair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun D.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bireswar","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagpal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip M.","family":"Friden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Narasimha","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.21711_bb0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CMR.11.3.415","article-title":"Onychomycosis: Pathogenesis, diagnosis, and management","volume":"11","author":"Elewski","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1002\/jps.21711_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1529-8019.2007.00109.x","article-title":"Toenail onychomycosis: Current and future treatment options","volume":"20","author":"Finch","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1002\/jps.21711_bb0020","first-page":"21","article-title":"Topical antifungal drugs for the treatment of onychomycosis: An overview of current strategies for monotherapy and combination therapy","volume":"19","author":"Baran","year":"2005","journal-title":"JEADV"},{"key":"10.1002\/jps.21711_bb0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1067\/mdm.2001.108128","article-title":"The use of the new oral antifungal agents, itraconazole, terbinafine, and fluconazole, to treat onychomycosis and other dermatomycoses","volume":"13","author":"Gupta","year":"2001","journal-title":"Curr Probl Dermatol"},{"key":"10.1002\/jps.21711_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(01)00989-9","article-title":"Drug delivery to the nail following topical application","volume":"236","author":"Murdan","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21711_bb0035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jps.10291","article-title":"Enhanced econazole penetration into human nail by 2-n-nonyl-1,3-dioxolane","volume":"92","author":"Hui","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21711_bb0040","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jps.10058","article-title":"Investigation of nail permeation enhancement by chemical modification using water as a probe","volume":"91","author":"Malhotra","year":"2002","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21711_bb0045","doi-asserted-by":"crossref","unstructured":"Van Hoogdalem EJ, van den Hoven WE, Terpstra IJ, van Zijtveld J, Verschoor JSC, Visser JN. Nail penetration of the antifungal agent oxiconazole after repeated topical application in healthy volunteers,and the effect of acetylcysteine. Eur J Pharm Sci 5:119\u2013127.","DOI":"10.1016\/S0928-0987(97)00270-4"},{"key":"10.1002\/jps.21711_bb0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijpharm.2008.01.027","article-title":"Chemical method to enhance transungual transport and iontophoresis efficiency","volume":"357","author":"Hao","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21711_bb0055","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1248\/cpb.46.1797","article-title":"Enhancing effect of N-acetyl-l-cysteine or 2-mercaptoethanol on the in vitro permeation of 5-fluorouracil or tolnaftate through the human nail plate","volume":"46","author":"Kobayashi","year":"1998","journal-title":"Chem Pharm Bull"},{"key":"10.1002\/jps.21711_bb0060","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/jps.20901","article-title":"In vitro penetration of novel oxaborole antifungal (AN2690) into the human nail plate","volume":"96","author":"Hui","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21711_bb0065","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1128\/AAC.46.12.3797-3801.2002","article-title":"Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine","volume":"46","author":"Tatsumi","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.21711_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00128071-200304010-00005","article-title":"Terbinafine: A review of its use in onychomycosis in adults","volume":"4","author":"Darkes","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1002\/jps.21711_bb0075","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2133.1992.tb00001.x","article-title":"Terbinafine: Mode of action and properties of the squalene epoxidase inhibition","volume":"126","author":"Ryder","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1002\/jps.21711_bb0080","first-page":"571","article-title":"Possible drug interactions in oral treatment of onychomycosis","volume":"87","author":"Katz","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1002\/jps.21711_bb0085","first-page":"302","article-title":"The use of terbinafine in the treatment of onychomycosis in adults and special populations: A review of the evidence","volume":"4","author":"Gupta","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"10.1002\/jps.21711_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200022010-00004","article-title":"A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis","volume":"22","author":"Gupta","year":"2000","journal-title":"Drug Safety"},{"key":"10.1002\/jps.21711_bb0095","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jps.20757","article-title":"Iontophoretic drug delivery across human nail","volume":"96","author":"Murthy","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21711_bb0100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jdermsci.2006.12.010","article-title":"Iontophoretic permselective property of human nail","volume":"46","author":"Murthy","year":"2007","journal-title":"J Dermatol Sci"},{"key":"10.1002\/jps.21711_bb0105","unstructured":"Nair AB, Vaka SRK, Sammeta SM, Kim HD, Friden PM, Chakraborty B, Murthy SN. in press. Transungual iontophoretic delivery of terbinafine. J Pharm Sci DOI: 10.1000.JPS\/21555."},{"key":"10.1002\/jps.21711_bb0110","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2133.1990.tb01453.x","article-title":"Determination of terbinafine in nail samples during systemic treatment for onychomycoses","volume":"123","author":"Dykes","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1002\/jps.21711_bb0115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3314\/jjmm.34.207","article-title":"Studies on the affinity of terbinafine with keratin","volume":"34","author":"Uchida","year":"1993","journal-title":"Jpn J Med Mycol"},{"key":"10.1002\/jps.21711_bb0120","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.2042-7158.1983.tb04258.x","article-title":"Physicochemical characterization of the human nail: Permeation pattern for water and the homologous alcohols and differences with respect to the stratum corneum","volume":"35","author":"Walters","year":"1983","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.21711_bb0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jps.10003","article-title":"Enhanced human nail drug delivery: Nail inner drug content assayed by new unique method","volume":"91","author":"Hui","year":"2002","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21711_bb0130","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.1002\/jps.21368","article-title":"Mechanistic study of electroosmotic transport across hydrated nail plates: Effects of ph and ionic strength","volume":"97","author":"Hao","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21711_bb0135","first-page":"1","article-title":"Equilibrium water sorption characteristics of the human nail","volume":"58","author":"Gunt","year":"2007","journal-title":"J Cosmet Sci"},{"key":"10.1002\/jps.21711_bb0140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0928-0987(01)00167-1","article-title":"Novel mechanisms and devices to enable successful transdermal drug delivery","volume":"14","author":"Barry","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.21711_bb0145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/000155557300304","article-title":"Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair, and nails during and after 250 mg terbinafine orally once per day for four weeks","volume":"73","author":"Faergemann","year":"1993","journal-title":"Acta Derm Venereol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915329348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915329348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T08:20:21Z","timestamp":1710231621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915329348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0022354915329348"],"URL":"https:\/\/doi.org\/10.1002\/jps.21711","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}